Cannara Biotech (DE:8CB0)
FRANKFURT:8CB0
Holding DE:8CB0?
Track your performance easily

Cannara Biotech (8CB0) Financial Statements

0 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently ―. The company's EPS TTM is €0.04; its P/E ratio is 10.12; Cannara Biotech is scheduled to report earnings on December 5, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
May 24Feb 24Nov 23Aug 23May 23
Income Statement-
Total RevenueC$ 27.56MC$ 27.21MC$ 19.48MC$ 18.28MC$ 15.94M
Gross ProfitC$ 13.77MC$ 14.67MC$ 7.94MC$ 6.89MC$ 6.12M
EBITC$ 3.55MC$ -3.45MC$ 3.49MC$ 6.55MC$ 4.31M
EBITDAC$ 5.07MC$ -1.99MC$ 5.11MC$ 7.87MC$ 5.59M
Net Income Common StockholdersC$ 2.02MC$ -3.45MC$ 2.11MC$ 4.63MC$ 2.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 5.46MC$ 3.13MC$ 2.64MC$ 4.27MC$ 4.03M
Total AssetsC$ 148.77MC$ 145.82MC$ 144.82MC$ 141.52MC$ 135.37M
Total DebtC$ 42.62MC$ 42.95MC$ 42.15MC$ 41.78MC$ 44.54M
Net DebtC$ 37.16MC$ 39.82MC$ 39.52MC$ 37.51MC$ 40.52M
Total LiabilitiesC$ 67.00MC$ 66.48MC$ 62.96MC$ 61.78MC$ 60.40M
Stockholders EquityC$ 81.77MC$ 79.34MC$ 81.86MC$ 79.74MC$ 74.98M
Cash Flow-
Free Cash FlowC$ 6.35MC$ 1.22MC$ -2.41MC$ 1.18MC$ -43.86K
Operating Cash FlowC$ 4.33MC$ 2.33MC$ 354.22KC$ 2.84MC$ 2.53M
Investing Cash FlowC$ -944.20KC$ -1.08MC$ -2.73MC$ -1.63MC$ -2.54M
Financing Cash FlowC$ -1.05MC$ -768.49KC$ 747.32KC$ -973.30KC$ -107.64K
Currency in CAD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis